Stockscreener 앱 받기
22.27
0.13%
0.03
시장 영업 전:
21.71
-0.56
-2.51%
전일 마감가:
$22.24
열려 있는:
$22.2
하루 거래량:
570.37K
Relative Volume:
0.97
시가총액:
$1.73B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
44.54
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
+1.09%
1개월 성능:
-8.20%
6개월 성능:
+27.48%
1년 성능:
-37.76%
1일 변동 폭
$22.12
$22.73
1주일 범위
$21.77
$24.36
52주 변동 폭
$16.80
$35.91
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
22.27 | 1.73B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra LifeSciences maintains $35 target, Market Outperform rating By Investing.com - Investing.com South Africa
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ... - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORP SEC 10-K Report - TradingView
Integra LifeSciences (IART) Stock Rises on Strong Q4 Results - GuruFocus.com
Integra LifeSciences Stock Surges 13.6% Post Q4 2024 ResultsNews and Statistics - IndexBox, Inc.
Integra: Q4 Earnings Snapshot - The Washington Post
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Integra LifeSciences Q4 2024 EPS beats, stock rises - Investing.com
Integra LifeSciences Guides FY25 In Line With View; Q4 Adj. EPS Tops Estimates - Nasdaq
INTEGRA LIFESCIENCES HLDGS Earnings Results: $IART Reports Quarterly Earnings - Nasdaq
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates - Yahoo Finance
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance - Yahoo Finance
Integra Lifesciences Q4 2024 Earnings: EPS Misses at $0.25, Reve - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Repor - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
INTEGRA LIFESCIENCES HLDGS Earnings Preview: Recent $IART Insider Trading, Hedge Fund Activity, and More - Nasdaq
Empowered Funds LLC Takes Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) to Release Earnings on Tuesday - Defense World
SHAREHOLDER ALERT: Morris Kandinov Investigating VG, ADSK, DKS, and IART; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IART 12-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - ACCESS Newswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences ... - The Bakersfield Californian
Integra LifeSciences (NASDAQ:IART) Shares Down 5.3%What's Next? - MarketBeat
Shareholders in Integra LifeSciences Holdings (NASDAQ:IART) have lost 63%, as stock drops 4.1% this past week - Yahoo Canada Finance
Choreo LLC Acquires 5,123 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (NASDAQ:IART) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Grabar Law Office is Investigating Claims on Behalf of - GlobeNewswire
Wound Closure Strips Market to Grow by USD 102.8 Million from 2025-2029, Driven by Focus on Reducing SSIs, Report with Market Evolution Powered by AITechnavio - The Malaysian Reserve
EVP, Chief Legal Officer & Sec, Schwartz Eric sold 4,070 shares of Integra Lifesciences Holdings Corp [IART] - Knox Daily
Integra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Down 6.1% in January - MarketBeat
Notice To Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Hamilton Spectator
Ready to Jump After Recent Trade: Integra Lifesciences Holdings Corp (IART) - SETE News
Integra LifeSciences to Release Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 - Yahoo Finance
Global Dental Surgery Instrument Market Regional Analysis [2025-2033] | 107 Pages Modern Report - WICZ
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) PT at $23.00 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Rating of “Reduce” from Brokerages - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Stock Holdings Decreased by Assenagon Asset Management S.A. - Defense World
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.40%
0.89%
자본화:
|
볼륨(24시간):